Erratum: Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study.
出版信息
Indian J Urol. 2019 Apr-Jun;35(2):176. doi: 10.4103/0970-1591.188609.
Abstract
[This corrects the article on p. 25 in vol. 35, PMID: 30692721.].
摘要
相似文献
1
Erratum: Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study.
Indian J Urol. 2019 Apr-Jun;35(2):176. doi: 10.4103/0970-1591.188609.
2
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study.
Int J Urol. 2019 Feb;26(2):192-200. doi: 10.1111/iju.13828. Epub 2018 Oct 25.
3
Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial.
Urologia. 2018 May;85(2):51-54. doi: 10.1177/0391560317749427. Epub 2018 Mar 26.
4
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
J Sex Med. 2013 Mar;10(3):857-65. doi: 10.1111/jsm.12039. Epub 2013 Jan 24.
5
Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
Int J Urol. 2013 Feb;20(2):193-201. doi: 10.1111/j.1442-2042.2012.03130.x. Epub 2012 Sep 7.
6
Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.
BJU Int. 2014 Oct;114(4):568-75. doi: 10.1111/bju.12733.
7
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.
Eur Urol. 2012 May;61(5):917-25. doi: 10.1016/j.eururo.2012.01.013. Epub 2012 Jan 20.
8
Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.
Neurourol Urodyn. 2020 Jan;39(1):237-242. doi: 10.1002/nau.24175. Epub 2019 Oct 2.
9
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study.
Int J Urol. 2019 Feb;26(2):200-201. doi: 10.1111/iju.13833. Epub 2018 Oct 25.
10
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
J Sex Med. 2017 Aug;14(8):1018-1027. doi: 10.1016/j.jsxm.2017.06.006.
本文引用的文献
1
Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study.
Indian J Urol. 2019 Jan-Mar;35(1):25-33. doi: 10.4103/iju.IJU_147_18.
Zotero 插件